Search clinical trials for: Tamuslosin

Total 222 results

Astellas Pharma Inc

Completed

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

Urinary Tract Diseases

Japan
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

Urination Disorders
Astellas Pharma Inc

Completed

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome

Urinary Tract Diseases

Japan
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

Prostatic Hyperplasia
Lawson Health Research Institute

Not yet recruiting

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial (PrePOURTS)

Urinary Retention Postoperative

Canada
Menoufia University

Completed

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Prostatic Neoplasms | Prostate Disease | Prostate Hypertrophy | Prostate Obstruction

Egypt
Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

Prostatic Hyperplasia
Samsung Medical Center

Unknown

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia
Hackensack Meridian Health

Recruiting

Post-operative Urinary Retention (POUR) Following Thoracic Surgery (POUR)

Urinary Retention

United States
Astellas Pharma China, Inc.

Completed

A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects

Healthy | Pharmacokinetics of Tamsulosin Hydrochloride

China
CHU de Quebec-Universite Laval
Fédération des médecins résidents du Québec

Not yet recruiting

Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection (R-POUR)

Colorectal Surgery | Urinary Retention | Post-operative Urinary Retention | Rectal Resection | Tamsulosin

Canada
GL Pharm Tech Corporation

Completed

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (GL2702)

Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Vanderbilt University
Actelion

Completed

Inhaled Iloprost in Mild Asthma

Asthma

United States
HaEmek Medical Center, Israel

Unknown

Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?

Kidney Stones

Israel
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Gundersen Lutheran Medical Foundation

Unknown

Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms

Ureteral Diseases

United States
Asan Medical Center
Astellas Pharma Inc

Unknown

Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy

Prostatic Neoplasms, Prostatectomy

Korea, Republic of
Feiran Lou
UMass Memorial Health Care

Recruiting

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin (POUR)

Thoracic Diseases | Urinary Retention

United States
Boehringer Ingelheim

Completed

An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Lower Urinary Tract Symptoms

United States
Assiut University

Unknown

The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms

Ureteric Stone
Boehringer Ingelheim

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
Samsung Medical Center

Unknown

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

Benign Prostatic Hyperplasia

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Terminated

Tamsulosin for Urinary Retention in Hospitalized Older Women (TAMSU)

Urinary Retention

France
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
Timothy Boone, MD, PhD
Astellas Pharma US, Inc.

Completed

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms

United States
McMaster University

Not yet recruiting

REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial (REPOURT-P)

Thoracic Surgery | Thoracic Epidural Analgesia | Urinary Catheterization
Andrew Meltzer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Tamsulosin for Urolithiasis in the Emergency Dept (STONE)

Ureterolithiases

United States
Astellas Pharma Inc
Boehringer Ingelheim; Astellas Pharma Europe Ltd.

Completed

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Benign Prostatic Hyperplasia
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Taiwan
Boehringer Ingelheim

Completed

Actual Use Study of Tamsulosin in Men

Urological Manifestations

United States
Ain Shams University

Completed

Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones: A Randomized Controlled Trial

Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones

Egypt
I.M. Sechenov First Moscow State Medical University

Completed

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Benign Prostatic Hyperplasia (BPH) | Lower Urinary Tract Symptoms (LUTS) | Ischaemic Heart Disease (IHD)
Azienda Ospedaliero Universitaria Maggiore della...

Recruiting

Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial (ProSeRePEA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Obstruction

Italy
Astellas Pharma Inc

Completed

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Czech Republic, Poland, Hungary, Belgium, Germany
University of California, Irvine

Enrolling by invitation

Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment

Nephrolithiasis

United States
The Cleveland Clinic

Active, not recruiting

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

Urinary Retention

United States
Joint-Stock Company North-West Center for Evidence-Based...

Not yet recruiting

The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract Symptoms

Bladder Hypersensitivity

Russian Federation
Boehringer Ingelheim

Completed

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Lower Urinary Tract Symptoms
Xintian Pharmaceutical

Completed

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis

China
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

Benign Prostatic Hyperplasia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

Benign Prostatic Hyperplasia

Korea, Republic of
Boehringer Ingelheim

Completed

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Prostate Hyperplasia

3

Subscribe